Watchlist Price Alert

Adamas Pharmaceuticals In... (ADMS)

NASDAQ: ADMS · Real-Time Price · USD

8.22

0.00 (0.00%)

At close: Apr 24, 2025, 3:47 PM

Adamas Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017	Q4 2016	Q3 2016	Q2 2016	Q1 2016
Period Ending	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016
Net Income	-19.52M	-12.34M	-12.57M	-18.27M	-11.92M	-10.57M	-16.65M	-23.07M	-27.58M	-24.87M	-29.66M	-28.88M	-33.15M	-33.99M	-34.97M	-29.36M	-23.36M	-20.75M	-16.03M	-14.96M	-14.39M	-16.88M	-13.83M
Depreciation & Amortization	134K	138K	138K	191K	200K	224K	236K	256K	266K	324K	368K	365K	361K	351K	383K	310K	312K	288K	284K	246K	234K	191K	137K
Stock-Based Compensation	1.87M	1.91M	1.74M	1.63M	1.63M	1.7M	1.48M	2.07M	4.46M	2.94M	3.38M	3.75M	4.14M	4.15M	3.74M	3.46M	3.26M	3.77M	2.88M	2.79M	2.6M	2.63M	2.55M
Other Working Capital	-476K	-1M	56.39M	-11.79M	-10.3M	-4.7M	-10.26M	-17.13M	-21.63M	-15.59M	-25.55M	3.56M	11.99M	11.18M	20.46M	53.34M	111.75M	119.14M	106.97M	107.24M	97.82M	150.49M	158.92M
Other Non-Cash Items	10.71M	-9K	-62.43M	21.71M	9.25M	3.57M	11.38M	19.99M	24.56M	17.4M	29.12M	-1.93M	-2.3M	-11.22M	-16.55M	-50.05M	11.8M	-8.16M	-807K	-7.12M	50.3M	10.47M	-58.91M
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	556K	1.13M	52.06M	-15.59M	-10.02M	-7.13M	-13.77M	-17.55M	-20.37M	-18.68M	-24.13M	3.09M	7.71M	8.13M	22.6M	50.82M	-7.39M	12.17M	-269K	9.42M	-52.67M	-8.43M	57.54M
Operating Cash Flow	-6.25M	-9.18M	-21.06M	-10.33M	-10.85M	-12.21M	-17.31M	-18.31M	-18.66M	-22.89M	-20.92M	-23.61M	-23.23M	-32.58M	-24.8M	-24.82M	-15.38M	-12.68M	-13.94M	-9.63M	-13.93M	-12.01M	-12.5M
Capital Expenditures	-8K	n/a	n/a	30K	n/a	n/a	n/a	n/a	n/a	-11K	-7K	613K	-1.18M	5K	-502K	-322K	-315K	-257K	-364K	-402K	22K	-783K	-461K
Cash Acquisitions	n/a	n/a	-1.33M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-3M	-26.82M	-2.5M	-37.12M	-5M	-29.98M	-33.96M	-37.22M	-17.99M	-17.85M	-20.81M	-15.57M	-989K	-4.9M	-178.9M	-5.99M	-16.45M	-33.08M	-6.99M	-8M	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	11.62M	29.91M	36M	26.97M	31M	49M	45.75M	44M	44M	38M	40.52M	24.76M	28.8M	29.08M	19.15M	23.3M	17.8M	31.65M	9.14M	21.58M	16.07M
Other Investing Acitivies	n/a	-30K	n/a	37.09M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-95.53M	n/a	n/a
Investing Cash Flow	-3.01M	-26.85M	7.79M	29.91M	31M	-3.01M	-2.96M	11.78M	27.76M	26.14M	23.18M	23.04M	38.35M	19.86M	-150.6M	22.77M	2.38M	-10.04M	10.44M	23.25M	-86.36M	20.8M	15.61M
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-921K	-8K	66.44M	1.27M	115K	223K	42K	338K	133K	548K	66K	400K	1.05M	2.38M	135.02M	71.24M	1.5M	35.42M	675K	342K	796K	2.08M	62.19M
Financial Cash Flow	-921K	-8K	66.44M	1.27M	115K	223K	42K	338K	133K	548K	66K	400K	1.05M	2.38M	135.02M	71.24M	1.5M	35.42M	675K	342K	796K	2.08M	62.19M
Net Cash Flow	-10.17M	-36.03M	53.17M	20.86M	20.27M	-15M	-20.23M	-6.2M	9.24M	3.8M	2.33M	-161K	16.16M	-10.34M	-40.37M	69.19M	-11.5M	12.7M	-2.82M	13.96M	-99.5M	10.87M	65.3M
Free Cash Flow	-6.25M	-9.18M	-21.06M	-10.3M	-10.85M	-12.21M	-17.31M	-18.31M	-18.66M	-22.9M	-20.92M	-22.99M	-24.41M	-32.58M	-25.3M	-25.15M	-15.7M	-12.94M	-14.3M	-10.03M	-13.91M	-12.79M	-12.96M